Archives

MicroAlgo Inc.’s Quantum Blockchain Architecture Using Cyclic QSC and QKD to Enhance Transaction Security and Transparency

B SHENZHEN, China, May 5, 2026 /PRNewswire/ — MicroAlgo Inc. (the “Company” or “MicroAlgo”) (NASDAQ: MLGO), today announced the use of a quantum blockchain architecture with… Login to continue reading Login…

Read MoreMicroAlgo Inc.’s Quantum Blockchain Architecture Using Cyclic QSC and QKD to Enhance Transaction Security and Transparency

TransCelerate and FDA Advance Collaboration on Streamlined Safety Data Collection to Accelerate Inclusion of Pragmatic Elements in Clinical Trials

B New report highlights practical application of selective safety data collection approaches to enable more efficient, real-world clinical research and expand patient access PHILADELPHIA, May… Login to continue reading Login…

Read MoreTransCelerate and FDA Advance Collaboration on Streamlined Safety Data Collection to Accelerate Inclusion of Pragmatic Elements in Clinical Trials

BGM0504 Achieves 19.3% Robust Weight Reduction, 16.5 cm Waist Circumference Decrease, Significant SBP/DBP Improvements of 22.9/12.9 mmHg, and 70.7 μmol/L Uric Acid Reduction; Phase III Trial Meets Primary Endpoint and All Key Secondary Endpoints

B SUZHOU, China, May 5, 2026 /PRNewswire/ — BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as ” BrightGene Bio-Medical” or “the Company”) announced that… Login to continue reading Login…

Read MoreBGM0504 Achieves 19.3% Robust Weight Reduction, 16.5 cm Waist Circumference Decrease, Significant SBP/DBP Improvements of 22.9/12.9 mmHg, and 70.7 μmol/L Uric Acid Reduction; Phase III Trial Meets Primary Endpoint and All Key Secondary Endpoints